Soliton found using ticker (SOLY) have now 3 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The range between the high target price and low target price is between 22 and 12 and has a mean target at 16. Now with the previous closing price of 8.37 this is indicating there is a potential upside of 91.2%. The day 50 moving average is 8.4 and the 200 moving average now moves to 8.22. The company has a market capitalisation of $177m. Find out more information at: http://www.soliton.com
The potential market cap would be $338m based on the market concensus.
Soliton, a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers product for the removal of tattoos. It also develops product for cellulite reduction, fibrotic scar treatment, and other indications. The company was founded in 2012 and is based in Houston, Texas.
